Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs113488022
rs113488022
BRAF
0.010 GeneticVariation BEFREE In conclusion, BRAF V600E mutation is likely to result in resistance to pazopanib but may be a potentianally actionable mutation in metastatic GEP-NETs patients. 26684240

2016
dbSNP: rs121913377
rs121913377
BRAF
0.010 GeneticVariation BEFREE In conclusion, BRAF V600E mutation is likely to result in resistance to pazopanib but may be a potentianally actionable mutation in metastatic GEP-NETs patients. 26684240

2016
dbSNP: rs397517132
rs397517132
EGFR
0.010 GeneticVariation BEFREE In conclusion, BRAF V600E mutation is likely to result in resistance to pazopanib but may be a potentianally actionable mutation in metastatic GEP-NETs patients. 26684240

2016
dbSNP: rs777980327
rs777980327
APC
0.010 GeneticVariation BEFREE In conclusion, BRAF V600E mutation is likely to result in resistance to pazopanib but may be a potentianally actionable mutation in metastatic GEP-NETs patients. 26684240

2016